← FDA DRUG APPROVALS

FDA ANDA · ANDA090243

VECURONIUM BROMIDE

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA090243
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-11
LATEST ACTION
2018-07-26
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VECURONIUM BROMIDEPrescription
VECURONIUM BROMIDE 10MG/VIAL · INJECTABLE · INJECTION
VECURONIUM BROMIDEPrescription
VECURONIUM BROMIDE 20MG/VIAL · INJECTABLE · INJECTION

Approval history

2018-07-26Labeling · Supplement 11 · standardAP
2010-11-23Labeling · Supplement 1AP
2010-05-11OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →